IRF3 and metabolic dysfunction-associated steatotic liver disease: Additionally, activation of the STING-IRF3 pathway was suggested to increase hepatocytes injury and dysfunction in NAFLD through stimulating apoptosis and inflammation, and dysregulating glucose and lipid metabolism [7].